Farid Saad Background: Men with hypogonadism are at increased risk of MACE and mortality. Studies in men with T2DM show that testosterone therapy (TTh) reduces both MACE and mortality.

Nov 1, 2011 · Effects on sexual interest appear after 3 weeks plateauing at 6 weeks, with no further increments expected beyond. Changes in erections/ejaculations may require up to 6 months. Effects on quality of life manifest within 3–4 weeks, but maximum benefits take longer.

Farid Saad has authored and co-authored more than 150 peer-reviewed papers and more than 700 scientific abstracts. He received honorary professorships in clinical research and endocrinology at Gulf Medical University, Ajman, U.A.E., and at Men’s Health Reproduction Study Center, Hang Tuah University, Surabaya, Indonesia, and serves as a ...

Since testosterone improves glycemic control in T2D, we investigated whether testosterone therapy (TTh) in men with hypogonadism and prediabetes prevents progression to T2D.

F. Saad: Adipositas und Hypogonadismus Die Indikation für eine TTh wird bei entsprechenden klinischen Symptomen, Testosteronwerten unterhalb des Normbe-reichs und dem Ausschluss von Kontrain-dikationen gestellt. Wesentliche Kontrain-dikationen sind Prostata- und Mammakar-zinom bzw. ein entsprechender Verdacht,

May 21, 2021 · 2 Consultant Medical Affairs, Bayer AG, Hamburg, Germany. Electronic address: [email protected]. Men with obesity and/or type 2 diabetes (T2D) have a high prevalence of testosterone deficiency (TD).

Farid Saad worked for various pharmaceutical companies as specialist for reproductive endocrinology, pediatric endocrinology, andrology, endocrinology of male aging, and hormonal male contraception in clinical development andrology, scientific and global medical affairs.

Principal Investigator: Farid Saad | ResearchGate, the professional network for scientists

Papers published by Prof. Dr. Farid Saad: Original Research Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data